搜索优化
English
全部
搜索
图片
视频
地图
资讯
Copilot
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
最新
最佳匹配
资讯
nai500
7 年
RedHill Biopharma宣布启动RHB-105 (TALICIA™)幽门螺杆菌感染验证性三期试验
RedHill Biopharma Ltd.(纳斯达克:RDHL) (特拉维夫股票交易所:RDHL) (“RedHill”或“公司”) 是一家专业生物制药公司,主要专注于开发并销售胃肠疾病和炎症性疾病及癌症治疗方面的处于后期临床试验阶段的专有口服小分子药物。本公司今天宣布RHB-105(新商标名称TALICIA ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Freed from detention
Judge halts Trump’s plan
Court blocks Louisiana law
Trump can keep control
China sends scores of planes
Says he was run off the road
Chocolates recalled
16 billion passwords leaked
Breaks hip in crash
On ICE raids at hotels, farms
Teen struck by lightning
Activists damage UK planes
Calls for special prosecutor
Chinese student sentenced
Brown pleads not guilty
To retire from figure skating
Falling rocks hit hikers
Alleged bomb threat probe
‘Hee Haw’ actor dies
Deezer adds AI song tags
Russian attack on Odesa
Says July rate cut possible
Revives terror victim suits
Buys minority stake in PSG
Allows firms to pick courts
Rearrested for wife’s murder
Refuses to expedite challenge
DEA informant charged
UK assisted dying bill
Unveils Oakley AI glasses
Kilauea volcano spews lava
反馈